Feb 17, 2026 08:30AM
Aug 14, 2025 08:00AM
Oct 9, 2023 08:54AM
Aug 11, 2021 08:00AM
Aug 11, 2021 08:00AM
Nov 19, 2020 09:26AM
Nov 18, 2020 05:42PM After-Hours Movers 11/18: (APVO) (CORT) (SONO) Higher; (WRN) (MGTX) (GPRO) Lower (more...)
Oct 28, 2020 04:30PM
Oct 28, 2020 04:30PM
Oct 5, 2020 05:58AM
Oct 3, 2020 10:50AM
Oct 3, 2020 10:50AM
Sep 22, 2020 08:32AM
Sep 22, 2020 08:30AM MeiraGTx Announces Data from Ongoing Clinical Trial of AAV-RPGR for the Treatment of X-Linked Retinitis Pigmentosa to be Presented at EURETINA 2020 Virtual Meeting
Sep 22, 2020 08:30AM
Aug 6, 2020 08:00AM
Aug 6, 2020 08:00AM
Aug 5, 2020 08:34AM
Aug 5, 2020 08:30AM
Aug 5, 2020 08:30AM
Jul 17, 2020 07:33AM MeiraGTx Holdings plc (MGTX) Reports Positive Clinical Data from Ongoing Phase 1/2 Clinical Trial (NCT03252847) of AAV-RPGR
Jul 17, 2020 07:30AM
Jul 17, 2020 07:30AM
May 7, 2020 04:30PM
May 7, 2020 04:30PM
Mar 11, 2020 05:00PM
Mar 11, 2020 05:00PM
Mar 2, 2020 08:32AM MeiraGTx (MGTX) Announces PPRIME) and ATMP Designations Granted by EMA to AAV-RPGR Gene Therapy for the Treatment of X-Linked Retinitis Pigmentosa
Mar 2, 2020 08:30AM
Mar 2, 2020 08:30AM
Dec 5, 2019 04:30PM
Dec 5, 2019 04:30PM
Nov 7, 2019 08:00AM
Nov 7, 2019 08:00AM
Sep 10, 2019 08:32AM MeiraGTx Holdings plc (MGTX) to Present Clinical Data from Phase 1/2 Trial of AAV-RPE65 at Upcoming Scientific Conferences
Sep 10, 2019 08:30AM
Sep 10, 2019 08:30AM
Aug 8, 2019 07:23AM
Aug 8, 2019 06:50AM
Aug 8, 2019 06:50AM
Aug 7, 2019 04:13PM
Aug 7, 2019 04:12PM MeiraGTx Announces Proposed Public Offering of Ordinary Shares
Aug 7, 2019 04:12PM
Aug 7, 2019 08:00AM
Aug 7, 2019 08:00AM
May 14, 2019 08:00AM
May 14, 2019 08:00AM
May 14, 2019 07:31AM
May 14, 2019 07:30AM MeiraGTx Announces Positive 6-Month Data from Phase 1/2 Trial of Investigational Gene Therapy AAV-RPE65 for RPE65-Deficiency
May 14, 2019 07:30AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All